Patent details
EP1359936 Title: COMBINED USE OF FACTOR VII POLYPEPTIDES AND FACTOR VIII POLYPEPTIDES
Basic Information
- Publication number:
- EP1359936
- PCT Application Number:
- PCT/DK/2002/000081
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP027107622
- PCT Publication Number:
- WO/2002/062377
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINED USE OF FACTOR VII POLYPEPTIDES AND FACTOR VIII POLYPEPTIDES
- French Title of Invention:
- UTILISATION COMBINEE DE POLYPEPTIDES DE FACTEUR VII ET DE POLYPEPTIDES DE FACTEUR VIII
- German Title of Invention:
- KOMBINIERTE VERWENDUNG VON FAKTOR VII POLYPEPTIDEN UND FAKTOR VIII POLYPEPTIDEN
- SPC Number:
Dates
- Filing date:
- 05/02/2002
- Grant date:
- 20/02/2008
- EP Publication Date:
- 20/02/2008
- PCT Publication Date:
- 15/08/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/11/2003
- EP B1 Publication Date:
- 20/02/2008
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 05/02/2009
- Expiration date:
- 05/02/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/02/2002
- Name:
- Novo Nordisk Health Care AG
- Address:
- Untere Heslibachstrasse 46, 8700 Küsnacht, Switzerland (CH)
Inventor
1
- Name:
- RØJKJÆR Rasmus
- Address:
- Denmark (DK)
2
- Name:
- HEDNER Ulla
- Address:
- Sweden (SE)
3
- Name:
- KNUDSEN Jens, Bjerre
- Address:
- Denmark (DK)
Priority
- Priority Number:
- 200100186
- Priority Date:
- 05/02/2001
- Priority Country:
- Denmark (DK)
Classification
- Main IPC Class:
- A61K 38/48;
| Filing date | Document type | Number of pages |
|---|